Constitutively active autophagy in macrophages dampens inflammation through metabolic and post-transcriptional regulation of cytokine production.
Study Design
- Jenis Studi
- In Vitro
- Populasi
- Beclin1 variant mice + AIEC infection
- Intervensi
- Constitutively active autophagy in macrophages dampens inflammation through metabolic and post-transcriptional regulation of cytokine production. Beclin1 constitutive activation (genetic)
- Pembanding
- Wild-type mice
- Luaran Utama
- Cytokine production in macrophage activation
- Arah Efek
- Positive
- Risiko Bias
- Unclear
Abstract
Autophagy is an essential cellular process that is deeply integrated with innate immune signaling; however, studies that examine the impact of autophagic modulation in the context of inflammatory conditions are lacking. Here, using mice with a constitutively active variant of the autophagy gene Beclin1, we show that increased autophagy dampens cytokine production during a model of macrophage activation syndrome and in adherent-invasive Escherichia coli (AIEC) infection. Moreover, loss of functional autophagy through conditional deletion of Beclin1 in myeloid cells significantly enhances innate immunity in these contexts. We further analyzed primary macrophages from these animals with a combination of transcriptomics and proteomics to identify mechanistic targets downstream of autophagy. Our study reveals glutamine/glutathione metabolism and the RNF128/TBK1 axis as independent regulators of inflammation. Altogether, our work highlights increased autophagic flux as a potential approach to reduce inflammation and defines independent mechanistic cascades involved in this control.
TL;DR
Increased autophagy dampens cytokine production during a model of macrophage activation syndrome and in adherent-invasive Escherichia coli infection and reveals glutamine/glutathione metabolism and the RNF128/TBK1 axis as independent regulators of inflammation.
Used In Evidence Reviews
Similar Papers
The Cochrane database of systematic reviews · 2018
Enteral nutritional therapy for induction of remission in Crohn's disease.
Gut · 2010
MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome.
The Cochrane database of systematic reviews · 2007
Enteral nutritional therapy for induction of remission in Crohn's disease.
Journal of pediatric gastroenterology and nutrition · 2000
Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease.
Alimentary pharmacology & therapeutics · 2003
Review article: nutrition and adult inflammatory bowel disease.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 1997